調査レポートカテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

Global Pruritus Drugs Market 2019-2023

掻痒薬の世界市場2019-2023

◆タイトル：Global Pruritus Drugs Market 2019-2023
◆商品コード：IRTNTR31704
◆調査・発行会社：Technavio (Infiniti Research Ltd.)
◆発行日：2019年7月20日
◆ページ数：143
◆資料形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：アジア、ヨーロッパ、北米、その他
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥265,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥318,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥424,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

 【資料の概要】

Technavio社の本調査レポートでは、掻痒薬の世界市場について調べ、掻痒薬の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、掻痒薬の市場規模をセグメンテーション別（用途別（血液掻痒、腫瘍性そう痒症、腎掻痒、内分泌掻痒、胆汁掻痒）、）と地域別（アジア、ヨーロッパ、北米、その他）に分けて算出しました。Technavio社は掻痒薬の世界市場規模が2019-2023期間中に年平均5%成長すると予測しています。
・サマリー
・レポートの範囲
・掻痒薬の市場状況
・掻痒薬の市場規模
・掻痒薬の市場予測
・掻痒薬の世界環境：ファイブフォース分析
・市場セグメンテーション：用途別（血液掻痒、腫瘍性そう痒症、腎掻痒、内分泌掻痒、胆汁掻痒）
・掻痒薬の顧客状況
・主要地域別市場規模：アジア、ヨーロッパ、北米、その他
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
　...

Global Pruritus Drugs Market: About this market

Pruritus drugs are used to treat itches associated with skin or systemic diseases. Technavio’s pruritus drugs market analysis considers sales from the topical, oral, and parenteral segments. The market is also segmented based on application into hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus. Our analysis also considers the sales of pruritus drugs in Asia, Europe, North America, and ROW. In 2018, the hematologic pruritus segment held the highest market share. However, the oncological pruritus segment will lead in terms of market share over the forecast period owing to rising oncological indications that cause pruritus. Almost all types of cancers put patients at increased risk of developing pruritus. Also, our global pruritus drugs report has observed market growth factors such as the growing preference for immunotherapy and rising prevalence of chronic diseases. However, the availability of alternative therapies, complex pathogenesis, and poor patient adherence may hamper the growth of the pruritus drugs industry over the forecast period.

Global Pruritus Drugs Market: Overview

Growing preference for immunotherapy

The rising use of immunotherapy drugs to treat oncological indications is increasing the incidence of pruritus. As a result, the demand for pruritus drugs such as topical emollients, antihistamines, and topical corticosteroids is increasing. The high efficacy of immunotherapy in treat cancer is not allowing patients to withdraw from the treat. Therefore, the growing preference for immunotherapy will help market vendors in increasing sales. This will contribute to the growth of the global pruritus drugs market at over 5% CAGR during the forecast period.

Nanoparticle-enabled transdermal drug delivery systems

Transdermal drug delivery is not effective in the delivery of small and lipophilic drugs. As a result, vendors have come up with nanoparticle-enabled transdermal drug delivery systems, which provide faster onset of action. They are also less painful compared with routes that require incisions. Moreover, biodegradable nanoparticles can prolong the duration of drug adhesion. These factors will increase the adoption of nanoparticle-enabled transdermal drug delivery systems, which will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global pruritus drugs market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global pruritus drugs market is fragmented. Technavio’s robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading Pruritus Drugs manufacturers, which include Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., and Sanofi.

Also, the pruritus drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY APPLICATION

Market segmentation by application

Comparison by application

Hematologic pruritus – Market size and forecast 2018-2023

Oncological pruritus – Market size and forecast 2018-2023

Renal pruritus – Market size and forecast 2018-2023

Endocrine pruritus – Market size and forecast 2018-2023

Cholestatic pruritus – Market size and forecast 2018-2023

Market opportunity by application

PART 08: MARKET SEGMENTATION BY ROA

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 15: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Allergan Plc

Astellas Pharma Inc.

GlaxoSmithKline Plc

Pfizer Inc.

Sanofi

PART 16: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 17: EXPLORE TECHNAVIO

 

Exhibit 01: Product overview

Exhibit 02: Global pharmaceuticals market

Exhibit 03: Segments of global pharmaceuticals market

Exhibit 04: Market characteristics

Exhibit 05: Market segments

Exhibit 06: Market definition – Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Five forces analysis 2018

Exhibit 11: Five forces analysis 2023

Exhibit 12: Bargaining power of buyers

Exhibit 13: Bargaining power of suppliers

Exhibit 14: Threat of new entrants

Exhibit 15: Threat of substitutes

Exhibit 16: Threat of rivalry

Exhibit 17: Market condition – Five forces 2018

Exhibit 18: Global pruritus drugs market pipeline: Overview

Exhibit 19: Global pruritus drugs market pipeline: Snapshot

Exhibit 20: Application – Market share 2018-2023 (%)

Exhibit 21: Comparison by application

Exhibit 22: Hematologic pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Hematologic pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 24: Oncological pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Oncological pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 26: Renal pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 27: Renal pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 28: Endocrine pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 29: Endocrine pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 30: Cholestatic pruritus – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: Cholestatic pruritus – Year-over-year growth 2019-2023 (%)

Exhibit 32: Market opportunity by application

Exhibit 33: RoA – Market share

Exhibit 34: Few prominent topical drugs

Exhibit 35: Customer landscape

Exhibit 36: Market share by geography 2018-2023 (%)

Exhibit 37: Geographic comparison

Exhibit 38: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: North America – Year-over-year growth 2019-2023 (%)

Exhibit 40: Top 3 countries in North America

Exhibit 41: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 42: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 43: Top 3 countries in Europe

Exhibit 44: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 45: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 46: Top 3 countries in Asia

Exhibit 47: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 48: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 49: Top 3 countries in ROW

Exhibit 50: Key leading countries

Exhibit 51: Market opportunity

Exhibit 52: Indications that are associated with pruritus

Exhibit 53: Impact of drivers and challenges

Exhibit 54: Vendor landscape

Exhibit 55: Landscape disruption

Exhibit 56: Vendors covered

Exhibit 57: Vendor classification

Exhibit 58: Market positioning of vendors

Exhibit 59: Allergan Plc – Vendor overview

Exhibit 60: Allergan Plc – Business segments

Exhibit 61: Allergan Plc – Organizational developments

Exhibit 62: Allergan Plc – Geographic focus

Exhibit 63: Allergan Plc – Segment focus

Exhibit 64: Allergan Plc – Key offerings

Exhibit 65: Allergan Plc – Key customers

Exhibit 66: Astellas Pharma Inc. – Vendor overview

Exhibit 67: Astellas Pharma Inc. – Business segments

Exhibit 68: Astellas Pharma Inc. – Organizational developments

Exhibit 69: Astellas Pharma Inc. – Geographic focus

Exhibit 70: Astellas Pharma Inc. – Key offerings

Exhibit 71: Astellas Pharma Inc. – Key customers

Exhibit 72: GlaxoSmithKline Plc – Vendor overview

Exhibit 73: GlaxoSmithKline Plc – Business segments

Exhibit 74: GlaxoSmithKline Plc – Organizational developments

Exhibit 75: GlaxoSmithKline Plc – Geographic focus

Exhibit 76: GlaxoSmithKline Plc – Segment focus

Exhibit 77: GlaxoSmithKline Plc – Key offerings

Exhibit 78: GlaxoSmithKline Plc – Key customers

Exhibit 79: Pfizer Inc. – Vendor overview

Exhibit 80: Pfizer Inc. – Business segments

Exhibit 81: Pfizer Inc. – Organizational developments

Exhibit 82: Pfizer Inc. – Geographic focus

Exhibit 83: Pfizer Inc. – Segment focus

Exhibit 84: Pfizer Inc. – Key offerings

Exhibit 85: Pfizer Inc. – Key customers

Exhibit 86: Sanofi – Vendor overview

Exhibit 87: Sanofi – Business segments

Exhibit 88: Sanofi – Organizational developments

Exhibit 89: Sanofi – Geographic focus

Exhibit 90: Sanofi – Segment focus

Exhibit 91: Sanofi – Key offerings

Exhibit 92: Sanofi – Key customers

Exhibit 93: Validation techniques employed for market sizing

Exhibit 94: Definition of market positioning of vendors



【掲載企業】

Allergan Plc, Astellas Pharma Inc., GlaxoSmithKline Plc, Pfizer Inc., and Sanofi.

★調査レポート[掻痒薬の世界市場2019-2023] (Global Pruritus Drugs Market 2019-2023 / IRTNTR31704)販売に関する免責事項
[掻痒薬の世界市場2019-2023] (Global Pruritus Drugs Market 2019-2023 / IRTNTR31704)についてEメールでお問い合わせ
◆関連調査資料◆
  • 選択的セロトニン再取り込み阻害薬（SSRI）の世界市場2019-2023
    IRTNTR31583 / Technavio / 2019年7月20日 / Technavio社の本調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場について調べ、選択的セロトニン再取り込み阻害薬（SSRI）の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、選択的セロトニン再取り込み阻害薬（SSRI）の市場規模をセグメンテーション別（用途別（うつ病、不安・パニック障害、その他の精神状態）、）と地域別（アジア、ヨーロッパ、北米、その他）に分けて算出しました。Technavio社は選択的セロトニン再取り込み阻害薬（SSRI）の世界市場規模が2019-2023期間中に年平均4%成長すると予測しています。 ・サマリー ・レポートの範囲 ・選択的セロトニン再取り込み阻害薬（SSRI）の市場状況 ・選択的セロトニン再取り込み阻害薬（SSRI）の市場規模 ・選択的セロトニン再取り込み阻害薬（SSRI）の市場予測 ・選択的セロトニン再取り込み阻害薬（SSRI）の世界環境：ファイブフォース分析 ・市場セグメンテーション：用途別（うつ病、不安・パニック障害、その他の精神状態） ・選択的セロトニン再取り込み阻害薬（SSRI）の顧客状況 ・主要地域別市場規模：アジア、ヨーロッパ、北米、その他...Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market: About this market Selective Serotonin Reuptake Inhibitors (SSRIs) are used to treat severe or persistent depression by elevating the extracellular levels of serotonin. Technavio’s selective serotonin reuptake inhibitors market analysis considers sales of the drugs for depression, anxiety and panic disorder, and other mental conditions. Our analysis also considers the sales of selective serotonin reuptake inhibitors in Asia, Europe, North America, and ROW. In 2018, the depression segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the rising incidence of depression, easy absorption...
  • ブドウ球菌感染症医薬の世界市場2019-2023
    IRTNTR31241 / Technavio / 2019年4月29日 / 当調査レポートでは、ブドウ球菌感染症医薬の世界市場について調査・分析し、市場概要、市場環境、ブドウ球菌感染症医薬市場規模、製品別（βラクタム、ペプチド、キノロン、マクロライド、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・ブドウ球菌感染症医薬の世界市場概要 ・ブドウ球菌感染症医薬の世界市場環境 ・ブドウ球菌感染症医薬の世界市場動向 ・ブドウ球菌感染症医薬の世界市場規模 ・ブドウ球菌感染症医薬の世界市場：業界構造分析 ・ブドウ球菌感染症医薬の世界市場：製品別（βラクタム、ペプチド、キノロン、マクロライド、その他） ・ブドウ球菌感染症医薬の世界市場：地域別市場規模・分析...About this market Regulatory agencies are granting special drugs designations for the development of drugs for the treatment of infectious diseases, including those used for the treatment of staphylococcal infection. Special drug designations offer incentives for the development of new drugs for the treatment which is encouraging more and more manufacturers to invest in the development of drugs, which in turn is driving the market. Technavio’ s analysts have predicted that the staphylococcal infection drugs market will register a CAGR of nearly 3% by 2023. Market Overview Increasing incidence of staphylococcal infections The emergence of antibiotics resistant strains has led...
  • 骨関節炎治療の世界市場2019-2023
    IRTNTR31047 / Technavio / 2019年3月27日 / 当調査レポートでは、骨関節炎治療の世界市場について調査・分析し、市場概要、市場環境、骨関節炎治療市場規模、製品別（鎮痛剤及びNSAIDs、副腎皮質ホルモン、関節内補充薬、その他）分析、種類別（足首骨関節炎、腰骨関節炎、膝骨関節炎、肩骨関節炎、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・骨関節炎治療の世界市場概要 ・骨関節炎治療の世界市場環境 ・骨関節炎治療の世界市場動向 ・骨関節炎治療の世界市場規模 ・骨関節炎治療の世界市場：業界構造分析 ・骨関節炎治療の世界市場：製品別（鎮痛剤及びNSAIDs、副腎皮質ホルモン、関節内補充薬、その他） ・骨関節炎治療の世界市場：種類別（足首骨関節炎、腰骨関節炎、膝骨関節炎、肩骨関節炎、その他）...About this market The increasing incidence of osteoarthritis will drive the osteoarthritis therapeutics market growth in the forthcoming years. Rising incidences of aging and obesity will directly contribute to the increasing prevalence of osteoarthritis in both developing and developed regions. Furthermore, the inflammation of adipose tissue and dyslipidemia associated with obesity is further expected to contribute majorly to the osteoarthritis therapeutics market growth in the forthcoming years. Technavio’s analysts have predicted that the osteoarthritis therapeutics market will register a CAGR of about 8% by 2023. Market Overview Availability of guidelines for disease management One of the growth drivers of the...
  • 小児用ワクチンの世界市場2019-2023
    IRTNTR30870 / Technavio / 2019年2月14日 / 当調査レポートでは、小児用ワクチンの世界市場について調査・分析し、市場概要、市場環境、小児用ワクチン市場規模、製品別（結合型ワクチン、弱毒生ワクチン、トキソイドワクチン、不活性化ワクチン）分析、種類別（単価ワクチン、多価ワクチン）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・小児用ワクチンの世界市場概要 ・小児用ワクチンの世界市場環境 ・小児用ワクチンの世界市場動向 ・小児用ワクチンの世界市場規模 ・小児用ワクチンの世界市場：業界構造分析 ・小児用ワクチンの世界市場：製品別（結合型ワクチン、弱毒生ワクチン、トキソイドワクチン、不活性化ワクチン） ・小児用ワクチンの世界市場：種類別（単価ワクチン、多価ワクチン）...Technavio Announces the Publication of its Research Report – Global Pediatric Vaccine Market 2019-2023 Technavio recognizes the following companies as the key players in the global pediatric vaccine market: CSL Limited, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the rising awareness of immunization in low- and- middle- income countries.” According to the report, one of the major drivers for this market is the strong late- stage pipeline and new drug approvals. Further, the report states that one of the...
  • 心筋症治療の世界市場2019-2023
    IRTNTR30336 / Technavio / 2018年12月3日 / 当調査レポートでは、心筋症治療の世界市場について調査・分析し、市場概要、市場環境、心筋症治療市場規模、種類別（拡張型心筋症、肥大型心筋症、その他）分析、製品別分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・心筋症治療の世界市場概要 ・心筋症治療の世界市場環境 ・心筋症治療の世界市場動向 ・心筋症治療の世界市場規模 ・心筋症治療の世界市場：業界構造分析 ・心筋症治療の世界市場：種類別（拡張型心筋症、肥大型心筋症、その他） ・心筋症治療の世界市場：製品別...About this market Advent of genomic medicine to push market growth during the forecast period. Cardiomyopathy is one of the major causes of heart failure. Genomic medicine is an emerging field in healthcare, it uses gene-related information of an individual. Technavio’s analysts have predicted that the cardiomyopathy therapies market will register a CAGR of almost 2% by 2023. Market Overview Initiative to increase awareness about disease There has been an increase in initiatives to spread awareness about cardiomyopathy among people in the last few years. High cost of treatment Cardiomyopathy makes it difficult for the heart to pump blood to...
  • 制酸薬の世界市場2019-2023
    IRTNTR30359 / Technavio / 2018年12月3日 / 当調査レポートでは、制酸薬の世界市場について調査・分析し、市場概要、市場環境、制酸薬市場規模、種類別（全身用、全身用以外）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・制酸薬の世界市場概要 ・制酸薬の世界市場環境 ・制酸薬の世界市場動向 ・制酸薬の世界市場規模 ・制酸薬の世界市場：業界構造分析 ・制酸薬の世界市場：種類別（全身用、全身用以外） ・制酸薬の世界市場：地域別市場規模・分析...About this market The global antacids market sees an increasing trend of online transactions as the market is dominated by OTC drugs that require no prescription. It is easy for the consumption to shop online without requiring prior extensive product knowledge. The major reason for the increased popularity of e- commerce retailing has been the retailer’s efforts on improving the online shopping experience through better online education and targeted marketing. This increases the comfort level of consumers buying a product online. Therefore, several organizations have come up to tap this market potential, thereby fueling market growth. Market Overview Increasing use...
  • 出血性脳卒中の世界市場2019-2023
    IRTNTR30243 / Technavio / 2018年11月21日 / 当調査レポートでは、出血性脳卒中の世界市場について調査・分析し、市場概要、市場環境、出血性脳卒中市場規模、製品別（抗高血圧症治療薬、抗凝固剤、利尿剤、抗痙攣剤）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・出血性脳卒中の世界市場概要 ・出血性脳卒中の世界市場環境 ・出血性脳卒中の世界市場動向 ・出血性脳卒中の世界市場規模 ・出血性脳卒中の世界市場：業界構造分析 ・出血性脳卒中の世界市場：製品別（抗高血圧症治療薬、抗凝固剤、利尿剤、抗痙攣剤） ・出血性脳卒中の世界市場：地域別市場規模・分析...About this market The improved diagnostic modalities for hemorrhagic stroke recovery to help market grow. For the appropriate management of hemorrhagic stroke, an adequate understanding of parenchymal hemorrhage is crucial. Since intracerebral hemorrhage is an acute clinical manifestation of the underlying cerebral small vessel diseases (cSVDs), it is essential to use improved diagnostic modalities such as MRI markers to monitor the risk stratification. Technavio’s analysts have predicted that the hemorrhagic stroke treatment market will register a CAGR of almost 4% by 2023. Market Overview Rising incidence in aging population Increasing age is a major risk for several conditions, including intracerebral...
  • 脳性麻痺治療の世界市場2019-2023
    IRTNTR30137 / Technavio / 2018年11月21日 / 脳性麻痺（CP)は、幼少期に起こる神経障害です。 一般的な脳性麻痺による症状としては、出生後5年以内の間に脳損傷によって引き起こされる運動機能障害、協調運動障害、および異常筋緊張があります。 Technavioのアナリストは、2019年から2023年の間に脳性麻痺治療の世界市場が5.42％のCAGRで成長すると予測しています。 主な分析対象企業は、Allergan、GlaxoSmithKline、Johnson & Johnson、Pfizerなどです。 当調査レポートでは、脳性麻痺治療の世界市場について調査・分析し、市場概要、市場環境、脳性麻痺治療市場規模、製品別（抗けいれん薬、鎮痙薬、抗コリン薬、NSAIDs、抗うつ薬、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・脳性麻痺治療の世界市場概要...About Cerebral palsy Cerebral palsy is a commonly occurring neurological disorder that occurs in early childhood. The usually occurring symptoms of CP are effects on movement, lack of coordination, and unusual muscle tone caused by cerebral damage within the first five years of birth. Technavio’s analysts forecast the Global Cerebral Palsy Treatment Market to grow at a CAGR of 5.42% during the period 2019-2023. Covered in this report The report covers the present scenario and the growth prospects of the cerebral palsy treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs...
  • 双極性障害治療の世界市場2019-2023
    IRTNTR30013 / Technavio / 2018年10月31日 / 双極性障害は、気分、エネルギー、および活動レベルの極端な変化を引き起こす躁うつ病としても知られています。気分変動の上昇は、躁病または軽躁病と呼ばれ、精神病の重症度および有無に基づいて異なります。双極性障害は、双極性I、双極性II、および循環性貧血に分類される長期持続性の疾患です。この疾患は、定期的な治療で管理できます。不眠、体重増加・減少、行動変化、および精神不安定は、双極性障害で見られる症状の一部です。双極性障害治療の世界市場は、2019～2023年の間に、年平均成長率2.38%で成長すると予測されています。 主な分析対象企業は、Allergan、AstraZeneca、Eli Lilly、GlaxoSmithKline、Johnson & Johnsonなどです。 当調査レポートでは、双極性障害治療の世界市場について調査・分析し、市場概要、市場環境、双極性障害治療市場規模、製品別（抗精神病薬、抗けいれん薬、従来の精神安定薬、その他）分析、市場動向、競争環境、主要地域別市場規模（北米、ヨーロッパ、アジアなど）、関連企業情報などを含め、以下の構成でお届け致します。 ・エグゼクティブサマリー ・調査範囲・調査手法 ・双極性障害治療の世界市場概要 ・双極性障害治療の世界市場環境...About Bipolar Disorder Bipolar disorder is also known as manic depression that causes extreme shifts in mood, energy, and activity levels. Elevated mood swings are called mania or hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized into bipolar I, bipolar II, and cyclothymia. This condition can be managed with a regular treatment. Insomnia, weight gain or loss, behavioral changes, and psychological imbalances are some of the symptoms witnessed in individuals with bipolar disorder. Technavio’s analysts forecast the Global Bipolar Disorder Therapeutics Market to grow at a CAGR...
  • 掻痒症治療薬の世界市場
    IRTNTR13976 / Technavio / 2017年8月2日 / 当調査レポートでは、掻痒症治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、掻痒症治療薬の世界市場規模及び予測、投与経路（ROA）別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。Technavio社は掻痒症治療薬の世界市場が2017-2021年期間中に年平均4.95%成長すると予測しています。当レポート上に記載されている主な企業は• Allergan• GlaxoSmithKline• Pfizer• Sanofi等です。...About Global Pruritus Therapeutic Pruritus is defined as the unpleasant skin sensation that frequently provokes scratching. Various systemic diseases are the major cause of pruritus. The intensity of sensation ranges from mild to severe. Various diseases cause changes/imbalance of biochemical factors, which trigger skin sensation and lead to pruritus. The market is segmented based on these disease conditions, which are responsible for pruritus. Technavio’s analysts forecast the global pruritus therapeutic market to grow at a CAGR of 4.95% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global pruritus...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆